Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Samay Raina's fun update on the return of India Got Latent, also announced a comeback tour.
Famous comedian Samay Raina is once again in the headlines. Recently, a question from the paparaz
Delhi Blast: Al Falah University under scrutiny, ED raids 25 locations in Delhi-Faridabad
The strings of the terrorist attack in Delhi have now reached Faridabad, Haryana. The Enforcement
The 20th match of IPL 2025 was played between RCB and Mumbai Indians. Batting first in this match
For the biggest gathering of faith Maha Kumbh, the railway will run 13 thousand trains in 45 days
The decision on the India-US trade agreement now rests with the US, as the Indian government has
Four boys died of drowning on Monday while bathing at Madhurapur Ganga Jahaj Ghat of Bhawanipur p
On Thursday, the last day of the first phase of the budget session in the Bengal Assembly, Educat
These days, America has come into the discussion about some of its big decisions around the world
'Supreme' hearing on the arrest of Sonam Wangchuk today, wife filed a petition
Sonam Wangchuk was arrested by the government after the violence in Leh. Sonam Wangchuk is curren
Aam Aadmi Party's national convenor and former Delhi CM Arvind Kejriwal has posted on X on the is
